Clinical Trials Logo

Clinical Trial Summary

Zhi Kang Capsule functions for hemostasis and detumescence and can be used for traumatic bleeding, uterine bleeding, hematemesis and hematochezia.This randomized controlled trial was conducted to confirm the efficacy and safety of Zhi Kang Capsule in the treatment of posttraumatic swelling and pain,and also in a wide range of applications by open clinical observation.


Clinical Trial Description

Limb fracture is a common disease in the Department of orthopedics, surrounding soft tissue swelling is the most common phenomenon of fracture and surgical treatment.The swelling, limb discomfort and increased pain seriously affecting the treatment effect.Therefore, prevention and treatment of limb swelling and perioperative pain is the main content of the treatment of fractures.

Post traumatic swelling and pain belong to the category of blood stasis syndrome in traditional Chinese medicine.Under the guidance of traditional Chinese medicine theory, traditional Chinese medicine plays a wide range of therapeutic effects, with a syndrome of multiple characteristics, but from the syndrome to the disease diagnosis and treatment process, more and more modern evidence based on medicine support are needed.A randomized controlled trial was carried out in the phase IV clinical trial to confirm the therapeutic effect of the capsule on posttraumatic swelling and pain. Meanwhile, an open clinical trial was conducted to evaluate the safety of the capsule in a wide range of applications.

The research subjects are patients with acute limb fractures within 2 weeks.The inclusion criteria are:(1) diagnosis of limb closed acute fracture, fracture occurred within 14 days, need for surgical treatment;(2) age ranged from 18 to 80 years old, both male and female;(3) voluntarily signed the informed consent form as the subjects.Test grouping include the capsule group and the placebo group.

The research consists of two parts: (1) the core research part: The core study was a placebo-controlled, randomized, double-blind, multicenter trial designed with 400 units of sample size, including 200 patients in the Zhi Kang Capsule group and 200 in the placebo group. The aim of the core study is to evaluate the effectiveness of test drugs. (2) the expanded research part: on the basis of core research,1800 cases were further divided into the capsule group. The aim of the expanded study was to evaluate the safety of the capsule in a large sample.

Criteria for efficacy evaluation include: pain score, swelling degree, lead flow, laboratory indicators and the first healing rate of surgical incision.All the statistical tests were two-sided, and the P value was less than or equal to 0.05, which would be considered statistically significant (except for the special description). The measurement data are described by means of mean, median, standard deviation, maximum, minimum, 25% and 75% quantiles; enumeration data or rank data are expressed in frequency and frequency. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03363971
Study type Interventional
Source Peking University People's Hospital
Contact
Status Enrolling by invitation
Phase Phase 4
Start date March 13, 2017
Completion date March 13, 2018

See also
  Status Clinical Trial Phase
Completed NCT02744144 - Wound Bacterial Microbiota and Their Antibiotic Resistance N/A
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Completed NCT05254470 - Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care
Recruiting NCT05171673 - Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury Phase 3
Not yet recruiting NCT05448807 - Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in Children Phase 3
Completed NCT02805751 - Early Controlled Loading on Conservative Treated Achilles Tendon Ruptures N/A
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Completed NCT04177537 - Real-World Experience of Athletes Treated With SAM
Not yet recruiting NCT04361773 - Effect of Photobiomodulation on the Treatment of Soft Tissue Traumatic Injuries Phase 1/Phase 2
Recruiting NCT05679284 - A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
Completed NCT04908748 - Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain Phase 2
Completed NCT01767727 - Repair of Multiple Finger Defects Using the Dorsal Homodigital Island Flaps N/A
Completed NCT05399771 - Radiofrequency Hyperthermia Safety Study N/A
Recruiting NCT03544632 - Acellular Adipose Tissue (AAT) for Soft Tissue Reconstruction Phase 2
Completed NCT05982353 - Gelatin Sponge VS PTFE Membrane for Socket Sealing After Immediate Implant Placement Phase 1
Completed NCT04802473 - Flap Thickness Upon Root Coverage With the Use of Acellular Dermal Matrix N/A
Completed NCT01626235 - AMPED Outcomes Registry of Post-ED Pain Management N/A
Completed NCT03049761 - Water Flosser vs String Floss vs Manual Toothbrush Safety N/A
Completed NCT02167646 - Bilaterally Innervated Sensory Dorsal Digital Flaps for Sensory Reconstruction of the Fingers N/A